Phosphorex and Dolomite Jointly Publish Articles to Discuss How Automation Benefits Development and Production of Lipid Nanoparticles (LNPs)

Hopkinton, MA, August 11, 2021 – Dr. Julia Rashba-Step, Phosphorex’ Vice President of R&D and Alliance Management, and Mr. Richard Gray, Commercial Director of Dolomite Bio, co-authored the article “Automated Lipid Nanoparticle Production: From Protocol Development to GMP Manufacture,” which was just published in the latest issue of the ONdrugDelivery magazine. The article discusses how automation of the lipid nanoparticle (LNP) production can benefit the development and manufacture of RNA-based drugs and vaccines.

Automated Lipid Nanoparticle Production: From Protocol Development To GMP Manufacture